In today's world, Dapiprazole has acquired increasing importance in different areas of society. From politics to technology, through culture and economics, Dapiprazole has become a topic of constant debate and general interest. Its implications and consequences are diverse and its influence is noticeable at all levels, affecting people's lives directly and indirectly. In this article, we will explore the different facets of Dapiprazole and analyze its impact on contemporary society, as well as possible solutions and alternatives to address its challenges.
| Clinical data | |
|---|---|
| AHFS/Drugs.com | Consumer Drug Information |
| MedlinePlus | a601043 |
| Pregnancy category |
|
| Routes of administration | Topical (eye drops) |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | Negligible when administered topically |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C19H27N5 |
| Molar mass | 325.460 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Dapiprazole (brand name Rev-Eyes) is an alpha-1 blocker. It is used to reverse mydriasis after eye examination.[1]